Arkolith/Insider Trading/ENVB/Form 4

Johnson David Ian

CEO and Chairman, DirectorEnveric Biosciences, Inc. (ENVB) · full profile →Form 4 · filed Feb 17, 2021
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
2
0 non-derivative · 2 derivative

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Feb 15, 2021Grant(A)1.3M—$01.3M
Feb 15, 2021Grant(A)53K—$01.4M

Transaction Codes

A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001493152-21-004174) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML